A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical TrialSai‐Hong Ignatius Ou, Trever G. Bivona, Susanna V. Ulahannan et al.|Journal of Thoracic Oncology|2020Cited by 74
Repurposing Asparaginase Therapy to Target Cisplatin‐Resistant Cancer CellsJ.S. Wang, Sean G. Rudd|Fundamental and Clinical Pharmacology|2025Cited by 2